Department of Thoracic Surgery, St Joseph Mercy Hospital, Ann Arbor, Mich.
Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative, Ann Arbor, Mich.
J Thorac Cardiovasc Surg. 2021 Nov;162(5):1375-1385.e1. doi: 10.1016/j.jtcvs.2020.10.162. Epub 2020 Dec 10.
Collaborative quality consortia can facilitate implementation of quality measures arising from clinical databases. Our statewide general thoracic surgery (GTS) collaborative investigated the influences of cigarette smoking status on mortality and major morbidity following lobectomy for lung cancer.
Society of Thoracic Surgeons General Thoracic Surgery Database records were identified from 14 institutions participating in a statewide thoracic surgical quality collaborative between 2012 and 2017. We excluded patients with nonelective procedures, stage 0 tumors, American Society of Anesthesiologists class VI disease, and missing clinical characteristics. Outcomes analysis included the combined mortality and major postoperative morbidity rates and the influence of patient characteristics, including smoking status, on composite rate and on postoperative complications.
The study cohort included 2267 patient records for analysis. Overall combined mortality and major morbidity rate was 10.2% (n = 231). Postoperative 30-day mortality was 1.5%, and major morbidity 9.6%. Significant predictors of the combined outcome included male sex (P = .004), body mass index (P < .001), Zubrod score (P = .02), smoking pack-years (P = .03), and thoracotomy (P < .001). Higher American Society of Anesthesiologists disease class and advanced tumor stage were marginally associated with worse combined outcome (P = .06). Smoking status; that is, current, past (no smoking within 30 days), or never smoked, was not associated with worse combined outcome (P = .56) and had no significant influence on major complications.
Smoking status was not associated with worse outcomes; however, smoking dose (pack-years) was associated with worse combined mortality and major morbidity. A statewide quality collaborative provides constructive feedback for participating institutions and surgeons, promoting quality improvement in perioperative patient care strategies and improved outcomes.
协作质量联盟可以促进临床数据库中产生的质量措施的实施。我们全州范围的普通胸外科 (GTS) 协作研究了吸烟状况对肺癌肺叶切除术后死亡率和主要发病率的影响。
从参与全州范围的胸外科质量协作的 14 个机构的胸外科协会数据库记录中确定了 Society of Thoracic Surgeons General Thoracic Surgery Database 记录,时间范围为 2012 年至 2017 年。我们排除了非选择性手术、0 期肿瘤、美国麻醉医师协会疾病分类 VI 级疾病以及临床特征缺失的患者。结果分析包括死亡率和主要术后发病率的综合率以及患者特征(包括吸烟状况)对综合率和术后并发症的影响。
研究队列包括 2267 例患者记录进行分析。总体合并死亡率和主要发病率为 10.2%(n=231)。术后 30 天死亡率为 1.5%,主要发病率为 9.6%。综合结果的显著预测因素包括男性性别(P=0.004)、体重指数(P<0.001)、Zubrod 评分(P=0.02)、吸烟包年数(P=0.03)和开胸术(P<0.001)。美国麻醉医师协会疾病分类较高和肿瘤分期较晚与较差的综合结果呈边缘相关(P=0.06)。吸烟状况,即当前、过去(30 天内不吸烟)或从未吸烟,与较差的综合结果无关(P=0.56),对主要并发症也没有显著影响。
吸烟状况与较差的结果无关;然而,吸烟量(包年)与死亡率和主要发病率的综合死亡率和主要发病率呈负相关。全州范围的质量协作为参与的机构和外科医生提供了建设性的反馈,促进了围手术期患者护理策略的质量改进和更好的结果。